Posts by Admin BioAlps
Pryv SA closes 1.1M CHF Pre-Series A to accelerate growth and prepare Series A funding round
Pryv SA, an independent Swiss Health-IT company, specialized in providing innovative data management and digital privacy solutions, is proud to announce the capitalization of CHF 1.1M from two former and two new investors. This amount will be used to consolidate the company’s operations. Now, Pryv SA launches its Series A “Growth” funding round which is…
Read MoreAlpine High-tech Venture Forum 10 October – Lausanne, Switzerland
Europe Unlimited, Canton de Vaud and BioAlps are pleased to invite you to be part to the Alpine High-tech Venture Forum (AHVF), which will take place on October 10th in Lausanne, Switzerland. The Alpine High-tech Venture Forum will showcase the most promising companies from Canton de Vaud, Switzerland, and Europe in the high innovation sectors:…
Read MoreRepenser les modèles d’affaires – Avantage compétitif à l’international le 28.09.2017
Le rendez-vous export des PME romandes SWISSTECH CONVENTION CENTER , EPFL, LAUSANNE Jeudi 28.09.2017 de 12:30 à 20:30 Les PME suisses sont passées maîtres dans l’art d’améliorer en continu l’efficacité de leurs produits et processus. Mais la pression sur leurs marges reste forte. Pour se forger un avantage compétitif à l’international, les PME suisses devront…
Read MoreE-health Summit
When Healthcare meets innovation Cette année, le forum suisse des TIC dans le système de santé Swiss eHealth Summit , qui se tiendra pour la première fois au “SwissTech Convention Center” situé à Ecublens et qui mettra plus amplement l’accent sur le thème de l’innovation. Prestataires de soin, industriels et représentants scientifiques et politiques se…
Read MoreSwiss-German Cooperation Days Biotechnologies 2017
Schlieren, 27.9.2017: Symposium Biotechnologies with Networking Event On behalf of the German Federal Ministry of Economic Affairs and in cooperation with our partners Swiss Biotech Association, Health Tech Cluster Switzerland, Biosaxony and BVMW the Swiss-German Cooperation Days Biotechnology will take place in Switzerland from (25th to 29th of September 2017. We invite you cordially to…
Read MoreSwiss-German Cooperation Days Biotechnologies (25.-29.9.2017)
27.9.: Symposium „Laboratory 4.0 and new solutions for efficient processes in biotechnology“ 26.-28.9.: Cooperation talks with potential partners from Germany On behalf of the German Federal Ministry of Economic Affairs and in cooperation with Swiss Biotech Association, Health Tech Cluster Switzerland, Biosaxony and BVMW the Swiss-German Cooperation Days Biotechnology will take place in Switzerland from…
Read More9th International Conference on Structural Biology
Structural Biology 2017 gladly welcomes all the participants from all over the world to join the upcoming prestigious event “9th International Conference on Structural Biology” to be held during September 18-19, 2017 at Zurich, Switzerland. Structural Biology 2017 gladly welcomes the participants from all over the world to join experts from 50+ countries under one…
Read Morenew funding opportunity for ‘Young Researchers’ Exchange Programme’ between Switzerland and Korea
20 fellowships PhD students and young postdocs from Swiss and Korean Universities and Research Institutes a new funding opportunity for ‘Young Researchers’ Exchange Programme’ between Switzerland and Korea to enable the mobility of young researchers. Applications are being accepted until 06 November 2017 . Target Group: 20 fellowships PhD students and young postdocs from Swiss and Korean Universities and Research Institutes…
Read MoreNHS Health & Care Innovation Expo
A pavilion showcasing Swiss innovative companies with Personalised Medicine solutions at NHS Innovation & Care Expo 2017 Swiss Pavilion – Manchestert – 11 & 12September 2017 WHY EXHIBIT AT NHS INNOVATION & CARE EXPO? NHS Innovation & Care Expo is the only exhibition where all the levels of the NHS are present and eager…
Read MoreAnergis Announces Results of the ATIBAR Trial
Anergis, a company developing proprietary ultra-fast allergy immunotherapy, announced today the top-line results from the ATIBAR trial, a Phase IIb field-based clinical trial with Anergis’ lead compound AllerT for patients with birch pollen allergy. Press release
Read More